Europäische Union -
Deutsch -
EMA (European Medicines Agency)
abiraterone accord
accord healthcare s.l.u. - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Europäische Union -
Deutsch -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abirateronacetat - prostata-neoplasmen - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Europäische Union -
Deutsch -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
singulair mini 4 mg kautabletten
organon healthcare gmbh (1007295) - montelukast-natrium - kautablette - montelukast-natrium (27913) 4,16 milligramm
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
montelubronch 10 mg filmtabletten
infectopharm arzneimittel und consilium gmbh (3291423) - montelukast-natrium - filmtablette - montelukast-natrium (27913) 10,4 milligramm
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
montelukast synthon 4 mg kautabletten
synthon b.v. (8010015) - montelukast-natrium - kautablette - teil 1 - kautablette; montelukast-natrium (27913) 4,16 milligramm
Österreich -
Deutsch -
AGES (Agentur für Gesundheit und Ernährungssicherheit)
montelukast ratiopharm 10 mg filmtabletten
teva b.v. - montelukast natrium - montelukast
Österreich -
Deutsch -
AGES (Agentur für Gesundheit und Ernährungssicherheit)
nidazea 7,5 mg/g - gel
dr. august wolff gmbh & co.kg - arzneimittel - metronidazol - metronidazol
Österreich -
Deutsch -
AGES (Agentur für Gesundheit und Ernährungssicherheit)
montelukast sandoz 4 mg - granulat
sandoz gmbh - montelukast natrium - montelukast
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
vizidor duo 20 mg/ml + 5 mg/ml augentropfen, lösung
bausch + lomb ireland limited (1009248) - dorzolamidhydrochlorid; timololmaleat - augentropfen, lösung - teil 1 - augentropfen, lösung; dorzolamidhydrochlorid (26539) 22,26 milligramm; timololmaleat (12113) 6,83 milligramm